Clene Inc. (CLNN): Cost of Revenue
$43.0K
Year ended 2025-12-31
$59.0K
Trailing 12 months to 2026-06-30
+18.3%
3-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $43.0K | -38.6% | 2026-03-17, From 2025-01-01 |
| 2024-12-31 | $70.0K | -42.1% | 2026-03-17, From 2024-01-01 |
| 2023-12-31 | $121.0K | +365.4% | 2025-03-24, From 2023-01-01 |
| 2022-12-31 | $26.0K | -91.0% | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | $289.0K | n/a | 2023-03-13, From 2021-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Clene Inc. (CLNN) | 2025-12-31 | $43.0K | -38.6% |
| Abvc Biopharma, Inc. (ABVC) | 2024-12-31 | $763 | -99.7% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $100.9K | +62.9% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $94.8K | n/a |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $100.1K | -23.4% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $147.3K | -53.8% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $44.3K | +658.7% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $215.0K | -98.2% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $404.8K | n/a |
Compare CLNN, ABVC, HIND, BFRG side by side · Screen every company in Pharmaceutical Preparations ↗